Sie sind auf Seite 1von 1

Ateneo de Zamboanga University College of Nursing

Drug Generic Name: Salbutamol Iprafropium Brand Name: (Combivent) Dosage: Route: Nebule Frequency: q8

Mechanism of Action Classification: Bronchodilator Beta2 Adrenergic agonist and anticholinergic Mechanism of Action: Beta2 adrenergic receptor cause bronchodilation and vasodilation Anticholinergic, blocks reflexes by antagonizing action of acetylcholine

Side Effects/ Adverse Effects Fatigue, abdominal pain, hypertension, dyspepsia, tachycardia, sinusitis, dysuria, urinary retention, weakness, edema, vomiting diarrheal constipation

Indication/ Contraindication Indication: Relief and prevention of bronchospasm in patients with airway obstructive disease Bronchodilator

Nursing Responsibilities

Monitor respiratory status, auscultate lungs before and after nebulization Report treatment failure or exacerbation of Contraindication: respiratory Patient with cardiac symptoms to tachyarrythmias, physician hypertropic Do not allow solution obstructive cardiomyopathy and or mist to enter the patient with history of eyes hypersensitivity

Das könnte Ihnen auch gefallen